News Amarin Corporation plc

Equities

AMRN

US0231112063

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-17 pm EDT			5-day change	1st Jan Change
0.758 ^USD	-2.58%		+20.70%	-12.87%

Jun. 12	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading	MT
Jun. 11	European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading	Jun. 12	MT
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading	Jun. 11	MT
European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading	Jun. 10	MT
Tech Firms Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	Jun. 06	MT
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	Jun. 05	MT
Sector Update: Health Care Stocks Rise Late Afternoon	Jun. 04	MT
Sector Update: Health Care Stocks Rise Tuesday Afternoon	Jun. 04	MT
Sector Update: Health Care	Jun. 04	MT
Amarin Shares Fall After CEO Resignation	Jun. 04	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	Jun. 04	MT
Amarin Names Aaron Berg as Chief Executive Officer	Jun. 04	MT
Amarin Board of Directors Announces CEO Transition	Jun. 04	GL
Amarin Board of Directors Announces CEO Transition	Jun. 04	AQ
Amarin Corporation plc Announces CEO Changes	Jun. 04	CI
Amarin Corporation plc Announces Executive Changes	Jun. 04	CI
AMARIN RECEIVES NATIONAL REIMBURSEMENT FOR VAZKEPA IN GREECE AND ANNOUNCES EXCLUSIVE MARKETING AND COMMERCIALIZATION AGREEMENT WITH VIANEX S.A.	May. 29	AQ
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading	May. 28	MT
Amarin Says Greece Approves Vazkepa for National Reimbursement; Signs Commercialization Agreement With Vianex	May. 28	MT
Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.	May. 28	GL
Amarin Corporation plc Receives National Reimbursement for Vazkepa (Icosapent Ethyl) in Greece by Greek Ministry of Health	May. 28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Amarin Corporation plc

Equities

AMRN

US0231112063

Summary

Filters